Author:
Zhou Mi,Bao Deying,Huang Hongyun,Chen Meining,Jiang Wenli
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Asgeirsson T, Zhang S, Senagore AJ (2010) Optimal follow-up to curative colon and rectal cancer surgery: how and for how long? Surgical oncology clinics of North America 19:861-873 https://doi.org/10.1016/j.soc.2010.06.003
2. Lee YC, Hsieh CC, Chuang JP (2013) Prognostic significance of partial tumor regression after preoperative chemoradiotherapy for rectal cancer: a meta-analysis. Dis Colon Rectum 56:1093-1101 https://doi.org/10.1097/DCR.0b013e318298e36b
3. Boras Z, Kondza G, Sisljagić V, Busić Z, Gmajnić R, Istvanić T (2012) Prognostic factors of local recurrence and survival after curative rectal cancer surgery: a single institution experience. Collegium antropologicum 36:1355-1361
4. Madbouly KM, Abbas KS, Hussein AM (2014) Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. American journal of surgery 207:824-831 https://doi.org/10.1016/j.amjsurg.2013.07.022
5. Sun RJ, Wang L, Li XT et al (2020) Baseline MRI detected lateral lymph node as a prognostic factor: a cohort study in pN0 low-risk rectal cancer. Journal of cancer research and clinical oncology 146:739-748 https://doi.org/10.1007/s00432-019-03100-0